M. Awad

发表论文 5 篇 · 总被引 312 次 · h-index 4

代表论文

• Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer (2010 · Journal of Clinical Oncology · 被引 268)
• Potential Predictive Markers of Benefit from Cetuximab in Metastatic Breast Cancer: An Analysis of Two Randomized Phase 2 Trials. (2009 · Cancer Research · 被引 19)
• K-Ras mutation (mut), EGFR-related, and exploratory markers as response predictors of cetuximab in first-line advanced NSCLC: Retrospective analyses of the BMS099 trial (2009 · Journal of Clinical Oncology · 被引 19)
• Association of a germ-line variant in the K-ras 3’ untranslated region with response and progression-free survival in patients with mCRC treated with single-agent cetuximab (IMCL-0144) or in combination with cetuximab (EPIC) independent of K-ras mutation status (2009 · Journal of Clinical Oncology · 被引 6)
• Accuracy of the Radiological Assessment of Tumor-to-Breast Volume Ratio by Sonomammography to Assist Planning of Oncosurgical Procedures in Breast Cancer (2023 · The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University)